Physician
Li, Wensong
Li, Wensong was paid $3.52M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 20611, — 28% of everything it billed.
33Billing provider infoLI, WENSONG
FLUSHING, NY 11355
FLUSHING, NY 11355
33aNPI1437146743assigned 10/03/2005
33bProvider typeAnesthesiology Physician
28Total paid$3.52M
24GClaims178,466
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in New York
Rank by total paid#11 of 493
Median peer was paid$8K
This provider vs. median457×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,473 | $233K | |
| 2019 | 31,100 | $375K | |
| 2020 | 15,043 | $252K | |
| 2021 | 23,471 | $535K | |
| 2022 | 32,708 | $809K | |
| 2023 | 32,778 | $703K | |
| 2024incomplete | 28,893 | $617K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 20611 | 28% | 41,726 | 18,343 | $993K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 25,185 | 21,804 | $582K |
| 64483 | 6.1% | 3,629 | 3,519 | $216K | |
| 64493 | 4.0% | 3,094 | 2,904 | $139K | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 3.8% | 8,915 | 3,463 | $135K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 2,947 | 2,944 | $129K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.6% | 4,239 | 3,902 | $127K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.3% | 2,587 | 970 | $116K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.9% | 3,278 | 1,299 | $102K |
| 64484 | 2.8% | 3,620 | 3,511 | $98K | |
| 62323 | 2.7% | 1,518 | 1,504 | $96K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 2.7% | 4,314 | 1,847 | $94K |
53 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2.4% | 3,193 | $85K |
| 99203 | Doctor's office visit, new patient (routine) | 1.9% | 2,139 | $68K |
| 64494 | 1.9% | 3,087 | $67K | |
| 64490 | 1.8% | 1,181 | $62K | |
| 27096 | 1.5% | 1,324 | $53K | |
| 64479 | 1.1% | 594 | $37K | |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | <1% | 1,626 | $35K |
| 97161 | <1% | 363 | $31K | |
| 64491 | <1% | 1,178 | $28K | |
| 64418 | <1% | 1,251 | $28K | |
| 64495 | <1% | 1,306 | $22K | |
| 64454 | <1% | 429 | $20K | |
| 64480 | <1% | 594 | $19K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 16,630 | $18K |
| 77002 | <1% | 858 | $16K | |
| 95886 | <1% | 364 | $15K | |
| 97162 | <1% | 179 | $15K | |
| 95911 | <1% | 258 | $13K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 5,188 | $12K |
| 97164 | <1% | 240 | $12K | |
| 64635 | <1% | 95 | $8K | |
| 64492 | <1% | 334 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 467 | $7K |
| 64640 | <1% | 100 | $6K | |
| 64636 | <1% | 94 | $4K | |
| 95923 | <1% | 106 | $3K | |
| 64450 | <1% | 108 | $2K | |
| 95913 | <1% | 41 | $2K | |
| 95912 | <1% | 12 | $670.10 | |
| 99442 | <1% | 22 | $555.46 | |
| 76942 | <1% | 16 | $211.09 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,733 | $103.22 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 1,750 | $11.70 |
| G9275 | Documentation that patient is a current non-tobacco user | <1% | 901 | $5.40 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 962 | $2.25 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 1,253 | $2.25 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 47 | $0.45 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | <1% | 140 | $0.45 |
| 3725F | 0% | 1,503 | $0.00 | |
| 3288F | 0% | 1,658 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 312 | $0.00 |
| 3077F | 0% | 383 | $0.00 | |
| 3078F | 0% | 858 | $0.00 | |
| 1100F | 0% | 12 | $0.00 | |
| 1101F | 0% | 1,501 | $0.00 | |
| 3075F | 0% | 269 | $0.00 | |
| 3008F | 0% | 2,995 | $0.00 | |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 0% | 10,898 | $0.00 |
| 3074F | 0% | 627 | $0.00 | |
| 1036F | 0% | 904 | $0.00 | |
| 3080F | 0% | 112 | $0.00 | |
| 1000F | 0% | 931 | $0.00 | |
| 3079F | 0% | 288 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.